Detalhe da pesquisa
1.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med
; 389(23): 2162-2174, 2023 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38055253
2.
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortium.
Int J Cancer
; 2024 May 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38709956
3.
Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
Br J Cancer
; 130(6): 934-940, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38243011
4.
Antitumor activity and safety of the PD-1 inhibitor retifanlimab in patients with recurrent microsatellite instability-high or deficient mismatch repair endometrial cancer: Final safety and efficacy results from cohort H of the POD1UM-101 phase I study.
Gynecol Oncol
; 186: 191-198, 2024 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38824752
5.
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study.
Gynecol Oncol
; 2024 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38834399
6.
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.
Int J Gynecol Cancer
; 34(4): 627-630, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38453176
7.
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer.
Int J Gynecol Cancer
; 34(4): 469-477, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38101816
8.
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.
Int J Gynecol Cancer
; 2024 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38627035
9.
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.
Gynecol Oncol
; 168: 68-75, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36401943
10.
Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI.
Int J Gynecol Cancer
; 33(12): 1890-1897, 2023 Dec 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37597854
11.
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer.
Gynecol Oncol
; 165(1): 14-22, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35177277
12.
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.
Int J Gynecol Cancer
; 32(6): 753-760, 2022 06 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35063943
13.
TRP channel expression correlates with the epithelial-mesenchymal transition and high-risk endometrial carcinoma.
Cell Mol Life Sci
; 79(1): 26, 2021 Dec 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34936030
14.
Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria.
Gynecol Oncol
; 162(3): 539-545, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34253389
15.
Comprehensive immunomolecular profiling of endometrial carcinoma: A tertiary retrospective study.
Gynecol Oncol
; 162(3): 694-701, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34253388
16.
Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced-stage ovarian cancer.
J Surg Oncol
; 123(4): 1109-1114, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33497468
17.
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial.
Int J Gynecol Cancer
; 31(4): 617-622, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33318079
18.
No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study.
Gynecol Oncol
; 159(3): 706-711, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33019981
19.
Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy.
Int J Gynecol Cancer
; 30(4): 466-472, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32079714
20.
Short-term surgical complications after radical hysterectomy-A nationwide cohort study.
Acta Obstet Gynecol Scand
; 99(7): 925-932, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31955408